Literature DB >> 25329002

Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.

Kazuyo Yasuda1, Toshihiko Torigoe1, Tasuku Mariya2, Takuya Asano2, Takafumi Kuroda3, Junichi Matsuzaki1, Kanae Ikeda4, Makoto Yamauchi4, Makoto Emori1, Hiroko Asanuma5, Tadashi Hasegawa5, Tsuyoshi Saito3, Yoshihiko Hirohashi1, Noriyuki Sato1.   

Abstract

Cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are defined as a small population of cells within cancer that contribute to cancer initiation and progression. Cancer-associated fibroblasts (CAFs) are stromal fibroblasts surrounding tumor cells, and they have important roles in tumor growth and tumor progression. It has been suggested that stromal fibroblasts and CSCs/CICs might mutually cooperate to enhance their growth and tumorigenic capacity. In this study, we investigated the effects of fibroblasts on tumor-initiating capacity and stem-like properties of ovarian CSCs/CICs. CSCs/CICs were isolated from the ovarian carcinoma cell line HTBoA as aldehyde dehydrogenase 1 high (ALDH1(high)) population by the ALDEFLUOR assay. Histological examination of tumor tissues derived from ALDH1(high) cells revealed few fibrous stroma, whereas those derived from fibroblast-mixed ALDH1(high) cells showed abundant fibrous stroma formation. In vivo tumor-initiating capacity and in vitro sphere-forming capacity of ALDH1(high) cells were enhanced in the presence of fibroblasts. Gene expression analysis revealed that fibroblast-mixed ALDH1(high) cells had enhanced expression of fibroblast growth factor 4 (FGF4) as well as stemness-associated genes such as SOX2 and POU5F1. Sphere-forming capacity of ALDH1(high) cells was suppressed by small-interfering RNA (siRNA)-mediated knockdown of FGFR2, the receptor for FGF4 which was expressed preferentially in ALDH1(high) cells. Taken together, the results indicate that interaction of fibroblasts with ovarian CSCs/CICs enhanced tumor-initiating capacity and stem-like properties through autocrine and paracrine FGF4-FGFR2 signaling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25329002     DOI: 10.1038/labinvest.2014.122

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  35 in total

Review 1.  Role of cancer-associated fibroblasts in breast cancer development and prognosis.

Authors:  Abdelilah Aboussekhra
Journal:  Int J Dev Biol       Date:  2011       Impact factor: 2.203

2.  CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells.

Authors:  Akihiro Tsuyada; Amy Chow; Jun Wu; George Somlo; Peiguo Chu; Sofia Loera; Thehang Luu; Arthur Xuejun Li; Xiwei Wu; Wei Ye; Shiuan Chen; Weiying Zhou; Yang Yu; Yuan-Zhong Wang; Xiubao Ren; Hui Li; Peggy Scherle; Yukio Kuroki; Shizhen Emily Wang
Journal:  Cancer Res       Date:  2012-04-03       Impact factor: 12.701

3.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

4.  HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells.

Authors:  Satoshi Nishizawa; Yoshihiko Hirohashi; Toshihiko Torigoe; Akari Takahashi; Yasuaki Tamura; Takashi Mori; Takayuki Kanaseki; Kenjiro Kamiguchi; Hiroko Asanuma; Rena Morita; Alice Sokolovskaya; Junichi Matsuzaki; Ren Yamada; Reona Fujii; Harm H Kampinga; Toru Kondo; Tadashi Hasegawa; Isao Hara; Noriyuki Sato
Journal:  Cancer Res       Date:  2012-05-02       Impact factor: 12.701

Review 5.  The cancer stem cell: premises, promises and challenges.

Authors:  Hans Clevers
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

6.  Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.

Authors:  Elisa Giannoni; Francesca Bianchini; Lorenzo Masieri; Sergio Serni; Eugenio Torre; Lido Calorini; Paola Chiarugi
Journal:  Cancer Res       Date:  2010-08-10       Impact factor: 12.701

7.  Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma.

Authors:  Akikazu Kawase; Genichiro Ishii; Kanji Nagai; Takeo Ito; Tatsuya Nagano; Yukinori Murata; Tomoyuki Hishida; Mitsuyo Nishimura; Junji Yoshida; Kazuya Suzuki; Atsushi Ochiai
Journal:  Int J Cancer       Date:  2008-09-01       Impact factor: 7.396

8.  Endothelial induced EMT in breast epithelial cells with stem cell properties.

Authors:  Valgardur Sigurdsson; Bylgja Hilmarsdottir; Hekla Sigmundsdottir; Agla J R Fridriksdottir; Markus Ringnér; Rene Villadsen; Ake Borg; Bjarni A Agnarsson; Ole William Petersen; Magnus K Magnusson; Thorarinn Gudjonsson
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

9.  CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133- cells.

Authors:  Celia Chao; J Russ Carmical; Kirk L Ives; Thomas G Wood; Judith F Aronson; Guillermo A Gomez; Clarisse D Djukom; Mark R Hellmich
Journal:  Lab Invest       Date:  2011-12-12       Impact factor: 5.662

10.  ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.

Authors:  Takafumi Kuroda; Yoshihiko Hirohashi; Toshihiko Torigoe; Kazuyo Yasuda; Akari Takahashi; Hiroko Asanuma; Rena Morita; Tasuku Mariya; Takuya Asano; Masahito Mizuuchi; Tsuyoshi Saito; Noriyuki Sato
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more
  22 in total

Review 1.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

2.  The Role of PIWIL4, an Argonaute Family Protein, in Breast Cancer.

Authors:  Zifeng Wang; Na Liu; Shuo Shi; Sanhong Liu; Haifan Lin
Journal:  J Biol Chem       Date:  2016-03-08       Impact factor: 5.157

3.  Dnajb8, a Member of the Heat Shock Protein 40 Family Has a Role in the Tumor Initiation and Resistance to Docetaxel but Is Dispensable for Stress Response.

Authors:  Masamichi Yamashita; Yoshihiko Hirohashi; Toshihiko Torigoe; Hiroki Kusumoto; Aiko Murai; Tomohiro Imagawa; Noriyuki Sato
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

Review 4.  The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment.

Authors:  Manuel Varas-Godoy; Gregory Rice; Sebastián E Illanes
Journal:  Stem Cells Int       Date:  2017-07-27       Impact factor: 5.443

5.  Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27.

Authors:  Kazuyo Yasuda; Yoshihiko Hirohashi; Tasuku Mariya; Aiko Murai; Yuta Tabuchi; Takafumi Kuroda; Hiroki Kusumoto; Akari Takaya; Eri Yamamoto; Terufumi Kubo; Munehide Nakatsugawa; Takayuki Kanaseki; Tomohide Tsukahara; Yasuaki Tamura; Hiroshi Hirano; Tadashi Hasegawa; Tsuyoshi Saito; Noriyuki Sato; Toshihiko Torigoe
Journal:  Oncotarget       Date:  2017-05-09

Review 6.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02

Review 7.  Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.

Authors:  Harriet R Ferguson; Michael P Smith; Chiara Francavilla
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

8.  Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.

Authors:  Takuya Asano; Yoshihiko Hirohashi; Toshihiko Torigoe; Tasuku Mariya; Ryota Horibe; Takafumi Kuroda; Yuta Tabuchi; Hiroshi Saijo; Kazuyo Yasuda; Masahito Mizuuchi; Akari Takahashi; Hiroko Asanuma; Tadashi Hasegawa; Tsuyoshi Saito; Noriyuki Sato
Journal:  Oncotarget       Date:  2016-03-08

9.  Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma.

Authors:  Sung Hee Lee; Nicole Kristina Rigas; Chang-Ryul Lee; April Bang; Sonal Srikanth; Yousang Gwack; Mo K Kang; Reuben H Kim; No-Hee Park; Ki-Hyuk Shin
Journal:  Oncotarget       Date:  2016-07-12

10.  ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway.

Authors:  Tadashi Ogawa; Yoshihiko Hirohashi; Aiko Murai; Toshihiko Nishidate; Kenji Okita; Liming Wang; Yuzuru Ikehara; Tetsuta Satoyoshi; Akihiro Usui; Terufumi Kubo; Munehide Nakastugawa; Takayuki Kanaseki; Tomohide Tsukahara; Goro Kutomi; Tomohisa Furuhata; Koichi Hirata; Noriyuki Sato; Toru Mizuguchi; Ichiro Takemasa; Toshihiko Torigoe
Journal:  Oncotarget       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.